Psychosis Archives - Page 3 of 4

Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

Feb 13, 2018

Lin C, Lin C, Chang Y, et al. Biological Psychiatry. Published online February 2018. DOI: https://doi.org/10.1016/j.biopsych.2017.12.006 Clozapine is the most effective antipsychotic medication currently available to treat psychosis. When it do...

Mortality Rates After the First Diagnosis of Psychotic Disorder in Adolescents and Young Adults

Feb 13, 2018

Simon GE, Stewart C, Yarborough BJ, et al. JAMA Psychiatry. Published online January 31, 2018. doi:10.1001/jamapsychiatry.2017.4437 People who develop psychosis are at increased risk of numerous problems including cardiovascular disease and dia...

AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial

Dec 14, 2017

Craig, Tom KJ et al. The Lancet Psychiatry , Volume 0 , Issue 0 , AVATAR therapy is a new therapy, developed by Julian Leff in the UK, during which people listening to a digital representation of their auditory hallucinations (voices) narrated by ...

Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis

Dec 14, 2017

Pillinger T, Beck K, Stubbs B, et al. The British Journal of Psychiatry Dec 2017, 211 (6) 339-349; DOI: 10.1192/bjp.bp.117.200907 People who develop psychosis (including schizophrenia) are at greater risk of developing high cholesterol and...

Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis

Jul 31, 2017

Schoeler T, Petros N, Di Forti M. Lancet Psychiatry. 10 July 2017. DOI: http://dx.doi.org/10.1016/S2215-0366(17)30233-X This study of almost 400 young people with first-episode psychosis showed that continued cannabis use predicted poor outc...

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- Or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial

Jul 31, 2017

JR Larsen et al. JAMA Psychiatry 74 (7), 719-728. 01 Jul 2017 Jul. Obesity is one of the most significant side-effects of antipsychotic medication. Current management of this problem includes weight monitoring, dietary advice and the use of gl...

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

Jul 31, 2017

Pagsberg A, Jeppesen P, Klauber DG, et al. Lancet Psychiatry 6 June 2017. DOI: http://dx.doi.org/10.1016/S2215-0366(17)30166-9 This rare double-blind, placebo-controlled head to head trial of antipsychotic medications quetiapine ER and aripipr...

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

Jun 26, 2017

Pagsberg AK, Jeppesen P, Kisubar DG, et al. DOI: http://dx.doi.org/10.1016/S2215-0366(17)30166-9 This is the first comparison of quetiapine ER (extended release) and aripiprazole in first episode psychosis and it showed no significant group diffe...

Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study

Apr 2, 2017

Lennox B, Palmer-Cooper EC, Pollack T et al. Lancet Psychiatry Jan 2017; 4(1):42-48 In recent years, anti-NMDA encephalitis has been shown to present with symptoms of first episode psychosis, leaving health professionals uncertain how commonly you...

Acceptance and Commitment Therapy for Psychosis: Randomised Controlled Trial

Mar 12, 2017

Shawyer F, Farhall J, Thomas N, et al. Br J Psychiatry. 2017 Feb;210(2):140-148. doi: 10.1192/bjp.bp.116.182865. Epub 2016 Dec 15. (Original) PMID: 27979820 During this trial of 96 people with psychosis, no group differences in overall mental s...

Archive

Archives for: Psychosis

Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial

Mortality Rates After the First Diagnosis of Psychotic Disorder in Adolescents and Young Adults

AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial

Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis

Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- Or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study

Acceptance and Commitment Therapy for Psychosis: Randomised Controlled Trial

Find us on